SECRETARIA DE GOBIERNO DE CIENCIA, TECNOLOGÍA E INNOVACIÓN PRODUCTIVA

Entrepreneurial management practices play a pivotal role in taking entrepreneurial knowledge and utilizing it towards innovation and talent development, ultimately creating growth and increasing the effectiveness of both new business venturing as well as small- and medium-sized enterprises (SMEs). EM4FIT investigates entrepreneurship and related management practices from an interdisciplinary and multi-level angel as important variables in the interplay between individual, organization and institutional contexts within and between advanced and emerging markets. EM4FIT aims to better understand entrepreneurial management practices both from an individual (intra-organisational) as well as comparative market perspective (inter-organisational). Research will be carried out with an emphasis on the impact of institutions and context on the EU. With the exchange among 16 partners from four continents and between the academic and non-academic sector, EM4FIT brings together knowledge from advanced as well as emerging markets to further understand how entrepreneurs and managers create successful businesses and foster growth. The generated knowledge will be disseminated around the world to enhance the impact of the European entrepreneurial spirit. Involving 67 researchers, managers, technical and administrative staff, the EM4FIT involves seven work packages (WP). In addition to project management and communication, dissemination and outreach activities, five WPs focus on research, training and dissemination at multiple levels: institutional-organizational-individual. With this project structure and the competitive capability of 16 partners involved, EM4FIT will generate high impact both in terms of research excellence and societal engagement. The mix between non-academic and academic participants is designed to create knowledge relevant for businesses and society alike.

In order to strengthen the global efforts on Personalized Medicine (PerMed) and the cooperation of the EU-CELAC countries to them, a unique Bi-regional consortium of governmental and funding organisations is shaped with the support of leading stakeholders as associated partners. This project has the ambition to engage CELAC countries in the International Consortium on Personalized Medicine (ICPerMed) and in the ERANet ERAPerMed with the aim at advancing in the implementation of the Action Plan of ICPerMed based in the Strategic Research and Innovation Agenda, drafted by PerMed2020. Research on PerMed is a top priority for the EU as a strategy aimed at delivering personalised health and care solutions to benefit citizens. Results of R&I actions will generate and translate knowledge on disease aetiology and technological innovation into personalised health and care solutions. Areas of application include chronic, rare and communicable diseases. Research under this priority will also attempt to develop an outstanding economic impact due to the potential of PerMed to transform health systems. The collaboration of diverse actors from different world regions, disciplines and health-care systems are needed to implement in a holistic way new feasible and cost-effective PerMed approaches. Involvement in ICPerMed of RFOs and policy-making bodies from EU and from other regions, is the best way to push forward the impact of new findings and knowledge in the area. This CSA will be the vehicle for: i) Mapping existing programmes, capacities and expertise and gaps in CELAC countries; ii) Facilitating the incorporation of CELAC countries in ICPerMed and in the ERAPerMed; iii) Fostering the participation of CELAC countries in research mobility and transnational projects on PerMed, and a platform for EU‐CELAC collaboration on clinical trials PerMed focused; iv) Cross-border learning from R&I and ELSA for implementing innovations between research capacities based in EU and CELAC.

The main ambition of AANChOR is to promote the implementation of the South Atlantic Research and Innovation Flagship initiative and the Belém Statement (BS), signed by the EU, Brazil and South Africa in 2017, to upscale research and innovation cooperation within the Atlantic basin, from Antarctica to the Arctic. AANChOR will pursue this ambition by providing the EC and the BS Implementation Committee (to be established by signatories of the Statement) with a framework to identify and contribute to the implementation of concrete long-term collaborative activities, reinforcing international cooperation between Europe and tropical and South Atlantic countries and connecting with the challenges and research needs of the North Atlantic Ocean. AANChOR will be responsible for launching a multi-stakeholder platform to identify collaborative activities, building on national and international ongoing initiatives such as the All Atlantic Ocean Research Alliance and addressing activities aimed at reinforcing capacity building, promoting academia-industry knowledge transfer for an enhanced ocean innovation, developing common standards, enhancing citizen awareness and ocean literacy and converging and aligning R&I infrastructure initiatives. To contribute to the implementation of the identified joint activities, AANChOR will provide seed money for the first development stages of selected joint pilot actions and support the identification of the most appropriate existing funding mechanisms and tools for further development of the selected activities. AANChOR will also define long term measures for the sustainability of the cooperation framework beyond the lifetime of the CSA. Recognising the evolving nature of the BS implementation, flexibility has been incorporated into the structure of the CSA allowing its activities adjustment wherever needed. The consortium brings together partners from 5 European Countries, 2 Latin American countries and 2 African countries.

EU-LAC ResInfra will identify a number of Latin America and Caribbean (LAC) Research Infrastructures (RIs) that may be considered eligible for the construction of a bi-regional collaboration. This will be carried out through the definition of minimal key requirements these RIs would need to develop in the coming years. To this aim, the Project will build on the prioritisation results of the EU-CELAC Senior Official Meeting on Science and Technology (SOM) Working Group (WG) on Research Infrastructures (RI) and, more specifically, will take as a reference the mapping exercises developed in previous EU funded projects. In addition, EU-LAC ResInfra will develop a map of National and Regional Research Infrastructure policies, and their corresponding strategies and plans, including funding mechanisms that might be used to support the construction and operation of future EU-LAC RIs. Furthermore, EU-LAC ResInfra will use all the results and information obtained for drafting a Sustainability Plan, which will be presented to the EU-CELAC WG RI for discussion and endorsement. The Plan will include specific actions to support the bi-regional collaboration in a mid-term perspective. The objectives are to design specific variable geometry instruments for co-funding RIs of common interest, and to design measures that pursue the strengthening of the bi-regional RI cooperation, seeking to maximise the impact of the RI collaboration in the construction of the EU-CELAC Common Research Area. Finally, the Project aims to show the feasibility of the EU-LAC RI collaboration through existing examples, thanks to the development of four Pilots in different scientific domains that are linked to some existing Research Infrastructures: INSTRUCT-ERIC, LIFEWATCH-ERIC, E-RIHS and RICAP.

EXEDRA, an EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials, will build on, and further support the structure and activities of JPIAMR to address the two major objectives of HCO-04-2016 topic: extending JPIAMR globally and creating a long-term sustainable structure for future expansion and governance which will coordinate national funding and collaborative actions supporting the implementation of the JPIAMR Strategic Research Agenda (SRA). JPIAMR EXEDRA will be the second Coordinated Support Action (CSA) for this Joint Programming Initiative (JPI) and essentially build on the work of the first CSA (JPIAMR), which ended February 2016. It will provide a strong support structure for the JPIAMR during the forthcoming implementation and expansion phaseby maintaining a continuity between the objectives, tasks and Work Packages of EXEDRA and JPIAMR. Support facilitated by the CSA EXEDRA will ensure that the ethos of joint programming in the area antimicrobial drug resistance becoming embedded within JPIAMR member’s research and innovation policies and programmes. EXEDRA will have the following work packages: WP1 Management and coordination; WP2 Strategy, governance, and long term sustainability; WP3 Internationalisation and capacity extension; WP4 Alignment with policy and industry; WP5 Research alignment; WP6 Communication, dissemination, and advocacy. EXEDRA will significantly contribute to the delivery of the JPIAMR SRA combined with the JPI-EC-AMR effort and the experience of the JPIAMR members. EXEDRA (and the JPIAMR) will support transnational cooperation to to pool substantial and long-term research funding and serve to complement other initiatives in the AMR area. It will create momentum with the potential to move the frontiers forward and offer new opportunities for industry, new tools for society, and new evidence-based data for policy makers, which will inspire other necessary initiatives.